Skip to main content
logo
Call
Menu

Saving you time is our focus

Our dedicated Specialty Testing Services team manages prior authorizations and helps navigate reimbursements to save you time and make our family of genetic tests more accessible.

  • QNatal® Advanced noninvasive prenatal screening*
  • QHerit® carrier screening*
  • Genetic carrier screens*
  • Hereditary cancer (BRCA) test*

Advanced screening with less complexity

We are committed to providing a more seamless experience for you and your patients.

Enhanced access

Simplified processes

In-network with most health

plans nationwide

Quanum® Solutions to order tests online and

manage practice services

Insurance verification and prior
authorization support

Interface with over 800 EHR systems

Pricing transparency and supplemental

financial assistance programs

MyQuest® online portal and app for patients

to access results

 

 

76% of insured patients pay less
than $99 for QNatal Advanced
noninvasive prenatal screening1

 

 

80% of insured patients
pay less than $25 for
QHerit carrier screening1

More time for patient care

Our dedicated Specialty Testing Services team is here for you, providing

time-saving prior authorization support for select advanced screenings.

Insights and support for you and your patients

Learn more about our advanced screening portfolios, education center, and patient assistance programs—all designed to make testing affordable and accessible.

QNatal® Advanced noninvasive prenatal screening
QHerit® carrier screening
Hereditary cancer (BRCA) test
Quanum® lab tools and IT systems
Clinical experts and education center
Patient assistance programs

 

 

Order today from

our Test Directory

Learn more

Your practice deserves specialized service

Register to stay informed about how we’re continuing to expand our services

566

* indicates required

* More information about QNatal Advanced, QHerit, other genetic carrier screens, and the Hereditary cancer (BRCA) test can be found at the following websites:

QNatal.com, QHerit.com, and QuestHereditaryCancer.com. As with any test, these tests may have false positives or false negatives. The positive predictive value of the tests vary based on the condition being tested, and may be lower for rare conditions. These tests are laboratory-developed tests that have been developed and validated, pursuant to the Clinical Laboratory Improvements Amendments of 1988 (CLIA), and as such they have not been reviewed by FDA.
 

Reference

1. National claims analysis. Data on file. Quest Diagnostics, 2021.

Our company

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.